51ÊÓƵ

Brain surgeons are bringing artificial intelligence and new imaging techniques into the operating room, to diagnose tumors as accurately as pathologists, and much faster, according to a report in the journal Nature Medicine. The new approach streamlines the standard practice of analyzing tissue samples while the patient is still on the operating table, to help guide brain surgery and later treatment. (Grady, 1/6)

The U.S. Food and Drug Administration's latest plan for overseeing clinical decision-support software leaves too much room for interpretation over what types of software the agency intends to regulate, according to health systems and software vendors. While stakeholders largely applauded the FDA's vision of a risk-based regulatory approach in theory, a major point of contention involves confusion over the FDA's definition of what software would be included under the FDA's oversight. (Cohen, 1/3)